A hemoperfusion column selectively adsorbs LAP+ lymphocytes to improve anti-tumor immunity and survival of tumor-bearing rats
Kazuo Teramoto, Yuji Ueda, Ryosuke Murai, Kazumasa Ogasawara, Misako Nakayama, Hirohito Ishigaki, Yasushi Itoh
The paper develops a hemoperfusion column that removes LAP+ lymphocytes, enhancing anti-tumor immunity and survival in tumor-bearing rats.
PLoS ONE · Mar 7, 2025Peer-reviewedImmunology